Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q2 2024 Earnings Call Transcript
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q2 2024 Earnings Call Transcript August 1, 2024Adaptive Biotechnologies Corporation beats earnings expectations.
Adaptive Biotechnologies Corp (ADPT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Viking Global Andreas Halvorsen | 29,993,708 | $108,577,223 | 0.41% | |
| 2. | Rubric Capital Management David Rosen | 14,000,000 | $50,680,000 | +34% | 1.32% |
| 3. | Matrix Capital Management David Goel And Paul Ferri | 11,572,590 | $41,892,776 | 0.31% | |
| 4. | ARK Investment Management Catherine D. Wood | 11,412,000 | $41,311,440 | +9% | 0.36% |
| 5. | Millennium Management Israel Englander | 9,262,341 | $33,529,674 | +1009% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.00 | 2,500 | Officer | 2,500 | 2019-07-01 | Filing | |
| $20.00 | 1,000 | Officer | 1,000 | 2019-07-01 | Filing | |
| $20.00 | 300 | Officer | 300 | 2019-07-01 | Filing | |
| $20.00 | 400 | Officer | 400 | 2019-07-01 | Filing | |
| $20.00 | 500 | Officer | 500 | 2019-07-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.50 | 26,922 | Officer | 139,365 | 2024-08-22 | Filing | |
| $3.43 | 7,727 | Officer | 123,318 | 2024-03-05 | Filing | |
| $3.44 | 6,609 | Officer | 166,287 | 2024-03-05 | Filing | |
| $3.43 | 6,772 | Officer | 172,896 | 2024-03-05 | Filing | |
| $3.44 | 1,813 | Officer | 253,745 | 2024-03-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,767,684 | $62,561,652 | 0% | |
| 2. | 11,421,554 | $55,965,614 | 0% | |
| 3. | 6,511,659 | $31,907,129 | 0.3% | |
| 4. | 6,511,659 | $31,907,129 | 0.02% | |
| 5. | 3,422,356 | $16,769,544 | 0.01% |
News See All
Does Adaptive Biotechnologies Corporation (ADPT) Have Strong Growth Potential?
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2024 Earnings Call Transcript
Adaptive Biotechnologies Corporation beats earnings expectations. Reported EPS is $-0.32586, expectations were $-0.35.
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript
Adaptive Biotechnologies Corporation beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.32.
Here’s Why Adaptive Biotechnologies Corporation (ADPT) Declined in Q4
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
16 Best Penny Stocks To Buy For 2024
The stock market’s optimism wave recently saw a break after latest data showed that the US labor market remains resilient despite consistent rate hikes to curb inflation.
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. At this time, I would like to welcome everyone to today’s Adaptive Biotechnologies 2023 Third Quarter Earnings Call.
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
Is it Still Worthy to Invest in Adaptive Biotechnologies (ADPT)?
Aristotle Atlantic Partners, an investment management firm, released its second quarter 2023 investor letter, a copy of which can be downloaded here.
Viking Global's Performance, AUM, and Long-Term Stock Picks
In this article, we discuss Viking Global's performance, AUM, and 10 long-term stock picks.
Billionaire Hedge Funds
